IGMS (IGM Biosciences, Inc.) Forward P/E Multiple

Corporate company logo of IGM Biosciences Inc. (IGMS)

High barriers to entry due to IgM antibody patents and stringent FDA oversight have cemented IGM Biosciences, Inc. (IGMS) as a scientific elite in the fight against cancer. The company's future P/E valuation on this GURU.Markets platform chart, where the current parameter is 0.00, reflects market expectations. Cost optimization and a strategic focus on autoimmune pathologies ensure the business's financial stability.

Projected Price to Earnings: igmbio.com (IGMS) for 07/04/2022 - 08/24/2025

Analytical breakdowns for IGM Biosciences, Inc.

- current price and projected stock value:
Summary company analytics:IGM Biosciences
Product sample of IGM Biosciences, Inc.

To build a high-quality portfolio, I utilize this indicator as a tool for assessing market expectations, where the current share price is divided by the expected profit of a future period. For IGM Biosciences, Inc. (IGMS), an R&D company burning capital to develop IgM antibodies, the projected P/E valuation allows for tracking the transition from expenditure to patent monetization, signaling whether the asset is overheated or undervalued.

Competitors of IGM Biosciences, Inc. (IGMS)

Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|VTYX (ventyxbio.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies Inc. THTX|Projected Price to Earnings AVTX (avalotx.com)|Projected Price to Earnings Eledon Pharmaceuticals, Inc. ELDN|Future Price to Earnings Agenus, Inc AGEN|Climb Bio Inc - Future Price to Earnings|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharma, Inc. ATYR|ADAG: Forward P/E Multiple|Price to Expected Earnings Ratio IMA (ImageneBio)|Projected Price to Earnings STTK|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Pharma (CNTB)|Forward P/E Multiple Immunic Therapeutics (IMUX)|Forward P/E Multiple ATRA (Atara Biotherapeutics)|Future Price to Earnings Multiple IFRX|XFOR (X4 Pharma) - Projected Price to Earnings Ratio|Future Price to Earnings Multiple ACET (adicetbio.com)|CELU: Forward P/E Multiple|inmunebio.com (INMB) - Forward P/E Multiple|BRNS (Barinthus Biotherapeutics PLC) - Forward P/E Multiple|KZR: Future Price to Earnings Multiple|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Future Price to Earnings Multiple|Future Price to Earnings Enlivex Therapeutics Ltd ENLV|QTTB - Projected Price to Earnings|geovax.com - Forward P/E Multiple|Future Price to Earnings Multiple EDSA (Edesa Biotech Inc)|IBIO: Forward P/E Multiple|Carisma Tx (CARM) - Forward P/E Multiple|XTLB (XTL Biopharmaceuticals) - Forward P/E Multiple|BOLT: Future Price to Earnings Multiple|Projected Price to Earnings HCWB (HCW Biologics, Inc.)|Forward P/E Multiple Aptevo (APVO)|Forward P/E Multiple AIM (aimimmuno.com)|Forward P/E Multiple Aditxt Corp ADTX|GRI: Projected Price to Earnings|Future Price to Earnings Multiple XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Future Price to Earnings|Revelation Bio (REVB) - Forward P/E Multiple|INDP (Indaptus Corp) - Forward P/E Multiple|SCNI: Future Price to Earnings Multiple|Forward P/E Multiple CALI|Projected Price to Earnings Affimed N.V. AFMD|Future Price to Earnings Allakos ALLK|HOOK: Price to Future Earnings Ratio|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple